Thermo Fisher Scientific (TMO) EBITDA (2016 - 2025)
Historic EBITDA for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.
- Thermo Fisher Scientific's EBITDA rose 560.39% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 462.72%. This contributed to the annual value of $7.3 billion for FY2024, which is 696.89% up from last year.
- As of Q3 2025, Thermo Fisher Scientific's EBITDA stood at $1.9 billion, which was up 560.39% from $1.8 billion recorded in Q2 2025.
- In the past 5 years, Thermo Fisher Scientific's EBITDA ranged from a high of $3.0 billion in Q2 2021 and a low of $1.6 billion during Q2 2023
- For the 5-year period, Thermo Fisher Scientific's EBITDA averaged around $2.0 billion, with its median value being $1.9 billion (2022).
- As far as peak fluctuations go, Thermo Fisher Scientific's EBITDA surged by 23653.42% in 2021, and later plummeted by 4459.41% in 2023.
- Over the past 5 years, Thermo Fisher Scientific's EBITDA (Quarter) stood at $2.5 billion in 2021, then fell by 26.67% to $1.9 billion in 2022, then decreased by 0.38% to $1.9 billion in 2023, then rose by 8.74% to $2.0 billion in 2024, then fell by 3.72% to $1.9 billion in 2025.
- Its last three reported values are $1.9 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.7 billion during Q1 2025.